Tag : Germany

CCT Impact

Cantourage brings first Ugandan medical cannabis to Germany through partnership with Israel’s Together Pharma

CCT IMPACT Agent
European medical cannabis leader Cantourage and Israeli medical cannabis producer Together Pharma (TASE: TGTR) have formed a partnership that will see the first Ugandan medical cannabis brought to Germany. From today, pharmacies and patients throughout Germany will have access to two of Together Pharma’s THC genetics: Glueberry OG® and Power Plant. The dried flower......
CCT Impact

Cantourage partners with FarmaGrowers to bring the first South African medical cannabis to Germany

CCT IMPACT Agent
European medical cannabis leaders Cantourage and South Africa-based farming enterprise FarmaGrowers have today confirmed an agreement to supply South African medical cannabis dried flower products to German pharmacies. The agreement means that Germany’s growing number of currently more than 128,0001 patients will now have access to South African medical cannabis dried flower products for......
CCT Impact

Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces its financial results for the quarter ended June 30, 2021. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All financial information in......
CCT Impact

Curaleaf International Launches Range of Medical Cannabis Products in Germany

CCT IMPACT Agent
Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced that wholly owned Curaleaf International subsidiary Adven GmbH (“Adven”) has launched its own range of medical cannabis products in Germany, Europe’s largest medical cannabis market.  The initial launch of a high THC oil product......
CCT Impact

Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully delivered EU-GMP medical cannabis product to Germany. In collaboration with Nimbus Health, a leading medical cannabis distributor in Germany, Khiron......
CCT Impact

Aphria Inc. Strengthens Leadership Position in Germany

CCT IMPACT Agent
Aphria Inc. (“Aphria,” “we,” or the “Company“) (TSX: APHA)  and (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their best life, today announced Denise Faltischek, Aphria’s Chief Strategy Officer, will also assume the role of Managing Director of Aphria Germany, effective January 23,......
CCT Impact

Panaxia is the first Israeli company to receive a marketing permit for medical cannabis products in Germany

CCT IMPACT Agent
The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (Panaxia Israel) (TASE: PNAX), Israel’s largest medical cannabis manufacturer and Neuraxpharm, its partner, Europe’s largest pharmaceutical company in the field of the central nervous system (CNS),  announced on Sunday the completion of the registration process and receipt of final regulatory approval from the health authorities in Germany, Europe’s largest and fastest-growing......
Market Watch

Khiron Signs Distribution Deal in Germany for Medical Cannabis Imports and Sales

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces that it has entered into an agreement with Nimbus Health, a leading German distributor of medical cannabis products.  Khiron branded EU GMP medical cannabis will soon......
Cannabis News Global Market Watch

Tilray Raises $60M to Expand Distribution Worldwide

Editor
Tilray, a global leader in medical cannabis research and production and wholly owned subsidiary of Privateer Holdings, announced today that the company has closed $60M from a recently closed Series A funding by a collection of global investors in the sector. Tilray, which holds legal licenses in Europe and Canada,......
Politics

German Police Call for the Decriminalization of Cannabis

Editor
BERLIN (AP) — The head of an organization representing German police is calling for the consumption of cannabis to be decriminalized. Germany has allowed some patients to get marijuana as a prescription medication since last March, but officials have stressed that doesn’t mean it will be legalized for non-medical purposes.......